Spots Global Cancer Trial Database for HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia
Official Title: HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia
Study ID: NCT01484171
Conditions
Study Description
Brief Summary: To compare the antitumor efficacy and toxicity of Idarubicin and cytarabine in combination with or not with infusions of granulocyte colony-stimulating factor-mobilized HLA-mismatched donor peripheral blood stem cells in patients with newly diagnosed high-risk acute myeloid leukemia (AML).
Detailed Description:
Eligibility
Minimum Age: 7 Years
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The Affiliated Hospital of the Chinese Academy of Military Medical Science, Beijing, Beijing, China
Contact Details
Name: huisheng ai, M.D.
Affiliation: The Affiliated Hospital of the Chinese Academy of Military Medical Science
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
